NPPA Fixes Retail Price of 19 Formulations; Details

Written by Ruchika Sharma Published On 2020-12-25T11:30:25+05:30 | Updated On 24 Dec 2020 2:21 PM IST

NPPA Fixes Retail Price of 19 Formulations; Details

New Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NCPA), Ministry of Chemicals and Fertilizers, Government of India has fixed price of 19 formulations.

These include formulations like Ibuprofen and Paracetamol Tablet; Vildagliptin and Metformin Hydrochloride (as sustained release) Tablet; Povidone IodineTopical Solution 1% and

This came in exercise of the powers conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. 1394(E) dated the 30th May, 2013 and S. O. 701(E) dated 10th March, 2016 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA), hereby fixes, the price as specified in column (6) of the table herein below as the retail price, exclusive of Goods and Services Tax, if any, in relation to the formulation specified in the corresponding entry in column (2) of the said Table with the strength, unit and name of manufacturer & marketing company, as specified in the corresponding entries in columns (3), (4) and (5) thereof;

Sl. No.	Name of the Formulation / Brand Name	Strength	Unit	Manufacturer & Marketing Company	Retail Price (Rs.)
(1)	(2)	(3)	(4)	(5)	(6)
1.	Mesalazine Suppositories BP 1g	Each Suppository contains: Mesalazine IP 1g	1 Suppos itory	M/s Bliss GVS Pharma Ltd. / M/s Cipla Limited	97.88
2.	Telmisartan + Chlorthalidone + Amlodipine Tablet	Each film coated tablet contains: Telmisartan IP 40mg, Chlorthalidone IP 6.25mg, Amlodipine Besilate IP eq. to Amlodipine 5mg	1 Tablet	M/s Micro Labs Limited	8.39
3.	Ceftiazone + Sulbactum for Injection (ZIFI SB)	The Combipack contains: Each vial contains: Ceftiazone Sodium IP eq. to Ceftriaxone 1000mg Sulbactum Sodium IP eq. to Sulbactum 500mg One ampoule of: Sterile Water for Injections IP 10ml	Per Combi Pack	M/s Zen Pharma (P) Limited / M/s FDC Limited	120.3 4
4.	Diclofenac + Thiocolchicoside + Linseed Oil + Methyl Salicylate + Menthol Gel	Composition: Diclofenac Diethylamine IP 1.16%w/w (eq. to Diclofenac Sodium 1.0%w/w), Thiocolchicoside IP 0.125% w/w, Linseed Oil BP 3% w/w, Methyl Salicylate IP 10%w/w Menthol IP 5%w/w	1 GM	M/s Pure and Cure Healthcare Pvt. Ltd. / M/s Zydus Healthcare Limited	5.23

Sl. No.	Name of the Formulation / Brand Name	Strength	Unit	Manufacturer & Marketing Company	Retail Price (Rs.)
(1)	(2)	(3)	(4)	(5)	(6)
5.	Ciprofloxacin + Dexamethasone Eye Drops	Composition: Ciprofloxacin Hydrochloride IP Eq. to Ciprofloxacin 0.3% w/v, Dexamethasone IP 0.1% w/v,	1 ML	M/s Skymap Healthcare Pvt. Ltd. / M/s Glensmith Labs Pvt. Ltd.	1.33
6.	Ciprofloxacin + Dexamethasone Eye Drops	Composition: Ciprofloxacin Hydrochloride IP Eq. to Ciprofloxacin 0.3% w/v, Dexamethasone IP 0.1% w/v,	1 ML	M/s Skymap Healthcare Pvt. Ltd.	1.33
7.	Phenylephrine HCl + Chlorpheniramin e Maleate + Sodium Citrate + Menthol Syrup	Each 5ml contains: Phenylephrine HCl IP 5mg, Chlorpheniramine Maleate IP 1mg Sodium Citrate IP 60mg, Menthol IP 1mg	1 ML	M/s Enicar Pharmaceuticals Pvt. Ltd. / M/s Group Pharmaceuticals Ltd.	0.90
8.	Omeprazole for Injection	Each vial contains: Omeprazole IP (Sterile) 40mg (As Sodium Suitably buffered) Water for Injection IP q. s.	Per Pack	M/s Skymap Healthcare Pvt. Ltd. / M/s German Remedies Pharmaceuticals Pvt. Ltd.	34.86
9.	Metoprolol Injection	Each ml contains: Metoprolol Tartrate IP 1mg Water for injection IP q. s.	Per Pack	M/s Skymap Healthcare Pvt. Ltd. / M/s German Remedies Pharmaceuticals Pvt. Ltd.	13.53
10.	Norethisterone Acetate Controlled Release Tablet	Each film coated controlled release tablet contains: Norethisterone Acetate BP 10mg	1 Tablet	M/s Akums Drugs & Pharmaceuticals Ltd. / M/s Cadila Pharmaceuticals Limited	15.09
11.	Ibuprofen + Paracetamol Tablet	Each uncoated tablet contains: Ibuprofen IP 400mg Paracetamol IP 325mg	1 Tablet	M/s Vapi Care Pharma Pvt. Ltd. /M/s Alembic Pharmaceuticals Lmited	1.11
12.	Moxifloxacin Hydrochloride + Dexamethasone Phosphate Eye Drops	Each ml contains: Moxifloxacin Hydrochloride IP eq. to Moxifloxacin 0.5% w/v Dexamethasone Sodium Phosphate IP eq. to Dexamethasone Phosphate 0.1% w/v	1 ml	M/s Skymap Healthcare Pvt. Ltd. / M/s Glensmith Labs Pvt. Ltd.	19.07

Sl. No.	Name of the Formulation / Brand Name	Strength	Unit	Manufacturer & Marketing Company	Retail Price (Rs.)
(1)	(2)	(3)	(4)	(5)	(6)
13.	Povidone-Iodine Gargle 0.5% w/v	Composition: Povidone-Iodine IP 0.5% w/v (available Iodine 0.06% w/v)	1 ml	M/s Windlas Biotech Pvt. Ltd. / M/s Mankind Pharma Limited	0.79
14.	Trihexyphenidyl Hydrochloride Tablet	Each uncoated tablet contains: Trihexyphenidyl Hydrochloride IP 1mg	1 Tablet	M/s D. D. Pharmaceuticals Pvt. Ltd.	0.73
15.	Azelnidipine + Telmisartan Tablet	Each film coated bi-layered tablet contains: Azelnidipine IP 8mg Telmisartan IP 40mg	1 Tablet	M/s Synokem Pharmaceuticals Limited / M/s Torrent Pharmaceuticals Ltd.	12.45
16.	Azelnidipine + Telmisartan Tablet	Each film coated bi-layered tablet contains: Azelnidipine IP 8mg Telmisartan IP 80mg	1 Tablet	M/s Synokem Pharmaceuticals Limited / M/s Torrent Pharmaceuticals Ltd.	14.20
17.	Vildagliptin + Metformin Hydrochloride (as sustained release) Tablet	Each uncoated bilayered tablet contains: Vildagliptin 50mg, Metformin Hydrochloride IP (As sustained release) 500mg	1 Tablet	M/s Exemed Pharmaceuticals / M/s Eris Life Sciences Limited	6.58
18.	Vildagliptin + Metformin Hydrochloride (as sustained release) Tablet	Each uncoated bilayered tablet contains: Vildagliptin 50mg, Metformin Hydrochloride IP (As sustained release) 1000mg	1 Tablet	M/s Exemed Pharmaceuticals / M/s Eris Life Sciences Limited	7.07
19.	Povidone IodineTopical Solution 1%w/v	Each 100ml contains: Povidone Iodine IP 1.0g (Available Iodine 0.1g) 2-Propanol IP 50g In an aqueous base	Per 200ml Pack	M/s G.S. Pharmbutor Pvt. Ltd./M/s Win- Medicare Pvt. Ltd.	92.00

The NPPA notice further added;

(a) The manufacturer of above mentioned formulations i.e. "new drug" under paragraph 2(u) of the DPCO, 2013 shall fix the retail price as specified in column (6) of the table hereinabove.

(b) The manufacturer may add Goods and Services Tax only if they have paid actually or it is payable to the Government on the retail price mentioned in column (6) of the above said table.

(c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.

(d) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.

(e) The above mentioned retail price is applicable only to the individual manufacturer / marketer as mentioned above i.e. who have applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to fulfilment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules, including manufacturing license permission from the Competent Authority i.e. the Central/State Licensing Authority, as may be applicable, by the concerned manufacturer/marketing companies.

(f) In case the retail price of any of the aforesaid formulations is not complied with, as per instant price notification and notes specified hereinabove, then the concerned manufacturer/marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955. (g) Consequent to the issue of ceiling price of such formulation as specified in column (2) of the above table in this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said date of notification, stand(s) superseded.

nppaParacetamolVildagliptinMetformin

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751